Dividend compounder review

ARGX

argenx NV ADR · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score60.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 25.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 15.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$1.3B
Free Cash Flow$573.5M
FCF Covers DividendUnknown
Debt / Equity0.64
P/E39.8
Revenue Growth 5Y151.5%
Net Margin31.4%
ROE27.4%
Price vs Trend10.0%
3Y Return125.4%
5Y Return184.8%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

ARGX dividend review warning Warning · Warning

No usable dividend history found.